Author profile
Editorial team for Peptide Therapy Guide.
From this author
Slu 332 Peptide Benefits What's New with Slu 332 Peptide Benefits: Fresh Reproducibility Data From My Work The perception of peptide molecules as advanced bioactive agents has been reinforced by widespread cov…
Read guide →Xen2174 is a 13-amino acid synthetic peptide. Xenome has completed a financing of A$8 million (roughly $6.22 million) to support the ongoing development of antipain medication Xen2174. It is a 13-amino acid sy…
Read guide →Hydrating And Peptide Boost Trend Roundup: Common Hydrating And Peptide Boost Blend Directions The positive trajectory of peptide research draws wider attention from industrial and academic research communitie…
Read guide →Synageva will receive $9 million up front under expanded deal. Synageva BioPharma and Mitsubishi Tanabe Pharma (MTPC) are expanding their rare disease agreement to develop a second protein therapeutic for an u…
Read guide →Development programs include cat, ragweed, dust mite, and grass allergy products. Allergy vaccine firm Circassia raised £60 million (about $97.72 million). The funding will be given in two tranches over two ye…
Read guide →Sources Of Peptides In Food The Unique Permeation Characteristics Of Sources Of Peptides In Food In Bio Systems The breakthrough of solid-phase synthesis techniques in the 1980s enabled the acquisition of cust…
Read guide →NVA237 significantly improved lung function in placebo-controlled Glow1 Study. Vectura announced that its licensee, Novartis, reported positive data from the first Phase III clinical trial with the once-daily …
Read guide →Revox Multi Peptide Sampon Understanding Buffer Compatibility Studies for Revox Multi Peptide Sampon Personalized peptide libraries are increasingly generated through sophisticated data-driven combinatorial sc…
Read guide →Deal could be worth over $290 million if all milestones are met for each of two targets. Pieris and Daiichi Sankyo signed a a collaboration and license agreement under which Pieris will use its Anticalin scaff…
Read guide →Heptares’ StaR technology will be used to generate stable receptor as basis of discovery program. Takeda Pharmaceutical is paying Heptares £1.7 million (about $2.7 million) up front and will make a £2.8 millio…
Read guide →RNA-Amp will be applied to generate gene-expression data. Epistem inked a three-year biomarker collaboration with GlaxoSmithKline (GSK) that aims to identify key features of diseased fibrotic tissue. The partn…
Read guide →Report from Withers & Rogers also found that biologics are making up a growing portion of applications. Big pharma pursued significantly fewer patents in 2009 compared to two years earlier, according to data f…
Read guide →Cleaving Peptides Industry Shifts Driving Wider Adoption of Cleaving Peptides Actives With the rapid advancement of genomics and proteomics, an increasing number of bioactive peptide sequences with potential r…
Read guide →Peptide Based Drug Delivery Systems Understanding Peptide Based Drug Delivery Systems:Practical Insights on Storage Temperature The global peptide sector has witnessed remarkable expansion over the past decade…
Read guide →Peptides And Nerve Damage Revisiting Peptides And Nerve Damage:Researcher's Perspective on Synthesis Scale-Up The perception of peptide molecules as advanced bioactive agents has been reinforced by widespread …
Read guide →Theramid Derma Peptides 30ml Serum Blemished Box Deconstructing Theramid Derma Peptides 30ml Serum Blemished Box:Molecular Journey of PEGylated Derivatives Successive waves of technological advancement have, o…
Read guide →Horizon Pharma said today it has agreed to acquire Crealta Holdings for $510 million in cash, in a deal that expands and broadens the buyer’s orphan drug business. The deal reflects Horizon Pharma’s long-range…
Read guide →UCLA's Amy Rowat, Ph.D., is investigating the texture and squishiness of cells in our body, which can have a huge impact on treatments for cancer and genetic disorders. She explains the mechanics of a cell and…
Read guide →Heptares Therapeutics said today it will partner with Pfizer to develop new drugs aimed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas. The collaboration could generate…
Read guide →University of Cambridge researchers writing in BMJ report that pharma companies involved in acquisitions and buybacks of stock often more than double the price of an acquired drug as a reward to shareholders w…
Read guide →